Filter
538
Filtered Results: 538
Text search:
immunocompromised
Featured
Recommendations
73
New Publications
92
Language
Document type
No document type
216
Guidelines
165
Studies & Reports
63
Manuals
29
Fact sheets
27
Strategic & Response Plan
17
Training Material
10
Infographics
5
Situation Updates
4
Brochures
1
Resource Platforms
1
Countries / Regions
India
33
Western and Central Europe
20
South Africa
16
Latin America and the Carribbean
13
Global
12
Kenya
10
Africa
8
Philippines
7
Middle East and North Africa
6
Nepal
5
Syria
5
Nigeria
5
West and Central Africa
5
South–East Asia Region
5
Eastern Europe
5
Ethiopia
5
Ukraine
4
Rwanda
4
Mozambique
4
Asia
4
Tanzania
4
Eastern Europe and Central Asia
4
East and Southern Africa
4
Russia
4
Malawi
3
Zimbabwe
3
Venezuela
3
Germany
3
Western Pacific Region
3
Brazil
3
Indonesia
3
Ghana
2
Chile
2
Niger
2
USA
2
Congo, Democratic Republic of
2
Argentina
2
Yemen
2
Mali
2
Zambia
2
Ecuador
2
Myanmar / Burma
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Mexico
1
El Salvador
1
Lesotho
1
Benin
1
Sierra Leone
1
Kazakhstan
1
Cameroon
1
Albania
1
Singapore
1
Laos
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Afghanistan
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
Haiti
1
Cambodia
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
North America
1
France
1
Tunisia
1
United Kingdom
1
Spain
1
Belarus
1
Israel
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Lebanon
1
Bangladesh
1
Vietnam
1
Uganda
1
Nicaragua
1
Namibia
1
Egypt
1
Sudan
1
Georgia
1
Honduras
1
Chad
1
Libya
1
South Sudan
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Eswatini/ Swaziland
1
Cuba
1
Pakistan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
151
Clinical Guidelines
91
Key Resources
19
Women & Child Health
18
Public Health
15
Pharmacy & Technologies
11
Capacity Building
6
Toolboxes
COVID-19
138
TB
84
HIV
36
Rapid Response
33
AMR
27
NTDs
25
Planetary Health
13
Refugee
11
Caregiver
10
Ebola & Marburg
9
Pharmacy
8
Cholera
7
Natural Hazards
6
Conflict
5
Polio
5
Mental Health
4
Zika
4
Global Health Education
4
Disability
3
Health Financing Toolbox
1
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is o...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
As vacinas COVID-19 são eficazes contra novas variantes? O que significa para uma pessoa estar totalmente vacinada? Essa e outras dúvidas estão entre as dúvidas mais frequentes sobre a vacinação contra a COVID-19. Nesta sexta edição você encontrará respostas para essas e outras perguntas.
...
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will support nurses on better action and also on communication towards
their patients and families.
180
Biomédica 2018;38:180-8
This document provides guidance on infection prevention and control (IPC) measures for people with suspected or confirmed coronavirus disease (COVID-19) who are experiencing mild symptoms that do not require hospitalisation, therefore self-isolating at home.
9 July 2021
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
The first case of COVID-19 was reported in Mozambique on 22 March 2020. As of 26 May, Mozambique had 194 confirmed cases of COVID-19, of which 168 were locally transmitted. The country’s capital, Maputo, and the province of Cabo Delgado are currently the epicentres of the outbreak in Mozambique, w...
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from ...
Infection control is the forth edition from Clinical Pocket Reference for Nurses.
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c...
